Exor N.V.

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed October 17, 2024), Exor N.V. reported 2 stock positions worth $5.9 billion. Its top holding was 0 at 91.8% of the portfolio, followed by Clarivate (CLVT, 8.2%). Its holdings were unchanged from Q2 2024.

Most Recent 13F
Q2 2026
Location
Amsterdam, P7
CIK
0001589122
Portfolio Value
$5.9B (Q3 2024)
SEC Filing
0000950123-24-009747 ↗ filed Oct 17, 2024

Holdings Value

0$2.0B$4.0B$6.0B Q1 2024: $3.3B Q1 2024 Q2 2024: $4.5B Q2 2024 Q3 2024: $5.9B $5.9B Q3 2024 Q4 2024: $4.5B Q4 2024 Q1 2025: $4.7B Q1 2025 Q2 2025: $4.7B Q2 2025 Q3 2025: $5.9B Q3 2025 Q4 2025: $5.6B Q4 2025 Q1 2026: $5.4B Q1 2026 Q2 2026: $5.5B Q2 2026

Holdings 2 stocks · $5.9B
0 91.85% 164,553,857 $5.4B No change
CLVT Clarivate PLC 8.15% 67,294,884 $477.8M No change

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$5.5B0, VIA, CLVT
Q1 2026 3$5.4B0, VIA, CLVT
Q4 2025 3$5.6B0, VIA, CLVT
Q3 2025 3$5.9B0, VIA, CLVT
Q2 2025 2$4.7B0, CLVT
Q1 2025 2$4.7B0, CLVT
Q4 2024 2$4.5B0, CLVT
Q3 2024 2$5.9B0, CLVT
Q2 2024 2$4.5B0, CLVT
Q1 2024 2$3.3B0, CLVT